Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 213
Newswise: Novel Agent Flips on 'Garbage Disposal' in Neurons, Eliminating Toxic Brain Proteins in Mice
  • Embargo expired:
    22-Oct-2019 2:00 PM EDT

Article ID: 720707

Novel Agent Flips on 'Garbage Disposal' in Neurons, Eliminating Toxic Brain Proteins in Mice

Georgetown University Medical Center

Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson’s and Alzheimer’s diseases, and improves cognitive and motor behavior.

Released:
18-Oct-2019 2:05 PM EDT
Open in New Tab
Comment
Newswise: Exposure to Environmental PCBs Impairs Brain Function In Mice
  • Embargo expired:
    22-Oct-2019 8:00 AM EDT

Article ID: 720703

Exposure to Environmental PCBs Impairs Brain Function In Mice

Georgetown University Medical Center

Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures.

Released:
18-Oct-2019 1:50 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    22-Oct-2019 12:05 AM EDT

Article ID: 720915

Aggressive Form of Breast Cancer Influenced by Dual Action of Genes and RNA

Georgetown Lombardi Comprehensive Cancer Center

Women with an aggressive, less-common type of breast cancer, known as triple-negative, versus a more common form of the disease, could be differentiated from each other by a panel of 17 small RNA molecules that are directly influenced by genetic alterations typically found in cancer cells.

Released:
18-Oct-2019 7:05 AM EDT
Open in New Tab
Comment
Embargo will expire:
25-Oct-2019 12:05 AM EDT
Released to reporters:
21-Oct-2019 12:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Oct-2019 12:05 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
23-Oct-2019 2:00 PM EDT
Released to reporters:
18-Oct-2019 1:55 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2019 2:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
23-Oct-2019 12:05 PM EDT
Released to reporters:
18-Oct-2019 7:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2019 12:05 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Georgetown_H_GUMC_blueRGB.jpg
  • Embargo expired:
    9-Oct-2019 1:00 PM EDT

Article ID: 720186

Finding Upends Theory about the Cerebellum’s Role in Reading and Dyslexia

Georgetown University Medical Center

New brain imaging research debunks a controversial theory about dyslexia that can impact how it is sometimes treated. The cerebellum, a brain structure traditionally considered to be involved in motor function, has been implicated in the reading disability, developmental dyslexia, however, this “cerebellar deficit hypothesis” has always been controversial. The new research shows that the cerebellum is not engaged during reading in typical readers and does not differ in children who have dyslexia.

Released:
4-Oct-2019 7:05 AM EDT
Open in New Tab
Comment

Article ID: 720088

Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia

Georgetown Lombardi Comprehensive Cancer Center

Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson’s and Alzheimer’s disease.

Released:
8-Oct-2019 7:05 AM EDT
Open in New Tab
Comment
  • Embargo expired:
    4-Sep-2019 11:00 AM EDT

Article ID: 718247

Georgetown Tobacco Control Expert Outlines Motivations of Altria-Juul Deal and Its Public Health Impact

Georgetown Lombardi Comprehensive Cancer Center

The pending deal for Altria to purchase 35% of Juul Labs should serve as a “wake-up call” for the careful monitoring of competition in the nicotine delivery market, and for evaluating how regulations and policies impact cigarette and non-cigarette firms selling alternative nicotine delivery products, says a Georgetown University professor.

Released:
29-Aug-2019 1:05 PM EDT
Open in New Tab
Comment
Newswise: Revealing the Molecular Engine That Drives Pancreatic Cancer Provides Ways to Turn It Off
  • Embargo expired:
    22-Aug-2019 11:00 AM EDT

Article ID: 717593

Revealing the Molecular Engine That Drives Pancreatic Cancer Provides Ways to Turn It Off

Georgetown Lombardi Comprehensive Cancer Center

Researchers have decoded a chain of molecules that are critical for the growth and survival of pancreatic ductal adenocarcinoma—the most common and also the most lethal form of pancreatic cancer.

Released:
16-Aug-2019 12:05 PM EDT
Open in New Tab
Comment

Showing results

110 of 213

Chat now!